Soleus Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Soleus Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.68M	Sell	575,000 -208,000	-27%	-$3.63M	0.3%	63
2026 Q1	$15M	Buy	+783,000	New	+$17M	0.61%	41
2025 Q3	–	Sell	-200,000	Closed	-$3.73M	–	109
2025 Q2	$3.73M	Sell	200,000 -296,039	-60%	-$5.86M	0.25%	64
2025 Q1	$9.5M	Buy	+496,039	New	+$14.5M	0.68%	39
2023 Q2	–	Sell	-203,300	Closed	-$8.26M	–	108
2023 Q1	$8.26M	Sell	203,300 -109,200	-35%	-$4.52M	0.85%	33
2022 Q4	$14M	Sell	312,500 -102,700	-25%	-$4.65M	2.02%	19
2022 Q3	$19.9M	Buy	415,200 +231,400	+126%	+$12.7M	2.7%	14
2022 Q2	$10.9M	Buy	+183,800	New	+$15.1M	1.7%	21
2020 Q1	–	Sell	-7,600	Closed	-$453K	–	60
2019 Q4	$453K	Buy	+7,600	New	+$469K	0.44%	37

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Soleus Capital Management's TNDM Position: Q2 2026 in Review

Soleus Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 27% in Q2 2026, selling an estimated $3.63M and leaving 575,000 shares worth $8.68M. The position accounts for 0.3% of the portfolio, ranked #63.

Soleus Capital Management first reported a position in TNDM in Q4 2019 and has held it in 9 quarters since. The position peaked at $19.9M in Q3 2022. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Soleus Capital Management held 575,000 shares of Tandem Diabetes Care worth $8.68M as of Q2 2026.
Soleus Capital Management sold 208,000 Tandem Diabetes Care shares in Q2 2026, an estimated $3.63M.
Tandem Diabetes Care made up 0.3% of Soleus Capital Management's portfolio in Q2 2026, its #63 holding.
Soleus Capital Management first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 9 quarters since.
Soleus Capital Management's Tandem Diabetes Care position peaked at $19.9M in Q3 2022.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.